Top Markets
#1 Siren Siren +31.61%
#2 OriginTrail OriginTrail +29.02%
#3 Tutorial Tutorial +14.64%
#4 MarsCoin MarsCoin +11.70%
#5 Waves Waves +10.84%
#6 Pons Pons +8.17%
#7 Synapse Synapse +7.21%
#8 Cortex Cortex +7.15%
#9 TROLL TROLL +6.08%
#10 Concordium Concordium +5.93%
Coin of the day
Siren Siren
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Kedudukan dalam Saham #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Harga Saham
$0.49606484
Disegerakkan terakhir: 2026-08-21
Modal Pasaran
$88.47M
Perubahan (1 hari)
-1.58%
Perubahan (1 tahun)
-22.51%
Negara
TW
Perdagangan Intech Biopharm Corporation (6461)

Kategori

Healthcare
Hasil untuk Intech Biopharm Corporation (6461)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Intech Biopharm Corporation, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Intech Biopharm Corporation dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH